Leadtek Research Inc.
TWSE:2465.TW
83.5 (TWD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,276.117 | 5,311.418 | 8,823.056 | 4,548.266 | 3,639.86 | 3,329.161 | 2,943.352 | 2,765.358 | 2,476.902 | 2,129.478 | 2,009.33 | 2,269.625 | 2,464.49 | 2,857.473 | 2,573.198 |
| Cost of Revenue
| 3,694.631 | 4,704.607 | 7,253.418 | 3,985.669 | 3,152.822 | 2,853.144 | 2,539.786 | 2,399.11 | 2,074.493 | 1,812.387 | 1,715.195 | 2,035.826 | 2,137.2 | 2,493.81 | 2,313.611 |
| Gross Profit
| 581.486 | 606.811 | 1,569.638 | 562.597 | 487.038 | 476.017 | 403.566 | 366.248 | 402.409 | 317.091 | 294.135 | 233.799 | 327.29 | 363.663 | 259.587 |
| Gross Profit Ratio
| 0.136 | 0.114 | 0.178 | 0.124 | 0.134 | 0.143 | 0.137 | 0.132 | 0.162 | 0.149 | 0.146 | 0.103 | 0.133 | 0.127 | 0.101 |
| Reseach & Development Expenses
| 203.806 | 188.631 | 205.619 | 146.969 | 148.561 | 121.918 | 106.334 | 139.062 | 139.121 | 150.595 | 139.086 | 142.23 | 148.615 | 180.84 | 224.081 |
| General & Administrative Expenses
| 150.559 | 111.575 | 159.893 | 114.387 | 104.669 | 120.785 | 40.986 | 43.921 | 37.91 | 33.426 | 28.56 | 23.247 | 29.782 | 32.548 | 35.119 |
| Selling & Marketing Expenses
| 378.792 | 452.085 | 649.953 | 251.161 | 217.293 | 246.253 | 90.623 | 108.722 | 109.733 | 78.554 | 72.651 | 59.956 | 65.678 | 90.052 | 100.867 |
| SG&A
| 476.201 | 563.66 | 809.846 | 365.548 | 321.962 | 367.038 | 131.609 | 152.643 | 147.643 | 111.98 | 101.211 | 83.203 | 95.46 | 122.6 | 135.986 |
| Other Expenses
| 10.773 | 28.066 | 8.567 | 8.889 | 9.016 | -36.268 | 77.101 | 4.68 | 3.297 | 5.904 | 7.362 | 32.193 | 7.29 | 24.452 | 11.498 |
| Operating Expenses
| 680.007 | 752.291 | 1,015.465 | 512.517 | 470.523 | 488.956 | 473.489 | 523.679 | 480.981 | 444.666 | 410.367 | 376.648 | 382.639 | 464.045 | 547.709 |
| Operating Income
| -98.521 | -168.579 | 560.084 | 72.166 | 17.878 | -12.939 | -69.923 | -157.431 | -78.572 | -127.575 | -116.232 | -142.849 | -55.349 | -100.382 | -288.122 |
| Operating Income Ratio
| -0.023 | -0.032 | 0.063 | 0.016 | 0.005 | -0.004 | -0.024 | -0.057 | -0.032 | -0.06 | -0.058 | -0.063 | -0.022 | -0.035 | -0.112 |
| Total Other Income Expenses Net
| -34.395 | -32.844 | -14.522 | -17.471 | -22.27 | -53.597 | -13.14 | -60.297 | 127.416 | -13.469 | 16.597 | 27.345 | 11.848 | 195.951 | -1.873 |
| Income Before Tax
| -132.916 | -201.423 | 545.562 | 54.695 | -4.392 | -66.536 | -83.063 | -217.728 | 48.844 | -141.044 | -99.635 | -115.504 | -43.501 | 95.569 | -289.995 |
| Income Before Tax Ratio
| -0.031 | -0.038 | 0.062 | 0.012 | -0.001 | -0.02 | -0.028 | -0.079 | 0.02 | -0.066 | -0.05 | -0.051 | -0.018 | 0.033 | -0.113 |
| Income Tax Expense
| 27.19 | -5.717 | 110.933 | 29.913 | 20.229 | 16.147 | 4.839 | -1.575 | 4.358 | 0.312 | 1.958 | 10.01 | 2.151 | 16.264 | 80.88 |
| Net Income
| -159.729 | -195.706 | 435.256 | 26.775 | -24.621 | -60.175 | -58.078 | -208.168 | 52.035 | -135.116 | -99.716 | -123.654 | -45.528 | 79.311 | -370.874 |
| Net Income Ratio
| -0.037 | -0.037 | 0.049 | 0.006 | -0.007 | -0.018 | -0.02 | -0.075 | 0.021 | -0.063 | -0.05 | -0.054 | -0.018 | 0.028 | -0.144 |
| EPS
| -2.53 | -3.32 | 7.38 | 0.45 | -0.42 | -1.02 | -0.99 | -3.53 | 0.89 | -2.29 | -1.69 | -2.1 | -0.77 | 1.34 | -6.29 |
| EPS Diluted
| -2.53 | -3.32 | 7.37 | 0.45 | -0.42 | -1.02 | -0.99 | -3.53 | 0.89 | -2.29 | -1.69 | -2.1 | -0.77 | 1.34 | -6.29 |
| EBITDA
| -45.293 | -118.782 | 602.72 | 120.853 | 64.369 | -14.424 | 51.232 | -143.115 | -55.217 | -81.174 | -61.563 | -78.479 | 5.321 | -30.476 | -205.539 |
| EBITDA Ratio
| -0.011 | -0.022 | 0.068 | 0.027 | 0.018 | -0.004 | 0.017 | -0.052 | -0.022 | -0.038 | -0.031 | -0.035 | 0.002 | -0.011 | -0.08 |